The nociceptin/orphanin FQ receptor partial agonist sunobinop promotes non-REM sleep in rodents and patients with insomnia

被引：0
|
作者：
Whiteside, Garth T. [1 ]
Kyle, Donald J. [2 ]
Kapil, Ram P. [1 ]
Cipriano, Alessandra [1 ]
He, Ellie [1 ]
Zhou, Mingyan [1 ]
Shet, Manjunath S. [1 ]
Hummel, Michele [2 ]
Knappenberger, Terri [2 ]
Fukumura, Kazuya [3 ]
Matsuo, Yoshiyuki [3 ]
Uehira, Masahiro [3 ]
Hiroyama, Shuichi [3 ]
Takai, Nozomi [3 ]
Willsie, Sandra K. [4 ]
Harris, Stephen C. [1 ]
机构：
[1] Imbrium Therapeut, Stamford, CT USA
[2] Purdue Pharma LP, Stamford, CT USA
[3] Shionogi & Co Ltd, Osaka, Japan
[4] Pharmaceut Res Associates, Raleigh, NC USA
来源：
JOURNAL OF CLINICAL INVESTIGATION | 2024年 / 134卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页数：3
相关论文
共 9 条
  • [1] ACTIVATION OF NOCICEPTIN/ORPHANIN-FQ PEPTIDE (NOP) RECEPTORS PRODUCES AN INCREASE IN NON-REM SLEEP IN RATS AND CONSTITUTES A NOVEL AND ATTRACTIVE TARGET FOR THE TREATMENT OF INSOMNIA
    Whiteside, G. T.
    Hummel, M.
    Knappenberger, T.
    Hiroyama, S.
    Itoh, T.
    Takai, N.
    Kyle, D. J.
    SLEEP, 2020, 43 : A1 - A1
  • [2] Activation of the nociceptin/orphanin-FQ receptor promotes NREM sleep and EEG slow wave activity
    Morairty, Stephen R.
    Sun, Yu
    Toll, Lawrence
    Bruchas, Michael R.
    Kilduff, Thomas S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2023, 120 (13)
  • [3] SAFETY, TOLERABILITY, AND EFFICACY OF A NOVEL, HIGHLY POTENT AND SELECTIVE PARTIAL AGONIST FOR NOCICEPTIN/ORPHANIN-FQ PEPTIDE (NOP) RECEPTORS IN PATIENTS WITH INSOMNIA DISORDER
    Zhou, M.
    Harris, S.
    Kapil, R.
    Cipriano, A.
    He, E.
    Shet, M.
    Fukumura, K.
    Matsuo, Y.
    Uehira, M.
    Zammit, G.
    SLEEP, 2020, 43 : A192 - A192
  • [4] Partial agonist behaviour depends upon the level of nociceptin/orphanin FQ receptor expression: studies using the ecdysone-inducible mammalian expression system
    McDonald, J
    Barnes, TA
    Okawa, H
    Williams, J
    Calo, G
    Rowbotham, DJ
    Lambert, DG
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 140 (01) : 61 - 70
  • [5] Pharmacodynamic characterization of ZP120 (Ac-RYYRWKKKKKKK-NH2), a novel, functionally selective nociceptin/orphanin FQ peptide receptor partial agonist with sodium-potassium-sparing aquaretic activity
    Kapusta, DR
    Thorkildsen, C
    Kenigs, VA
    Meier, E
    Vinge, MM
    Quist, C
    Petersen, JS
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 314 (02): : 652 - 660
  • [6] SR 16435 [1-(1-(bicyclo[3.3.1]nonan-9-yl)piperidin-4-yl)indolin-2-one], a novel mixed nociceptin/orphanin FQ/μ-opioid receptor partial agonist:: Analgesic and rewarding properties in mice
    Khroyan, Taline V.
    Zaveri, Nurulain T.
    Polgar, Willma E.
    Orduna, Juan
    Olsen, Cris
    Jiang, Faming
    Toll, Lawrence
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (02): : 934 - 943
  • [7] Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist, 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Design, Synthesis, and Structure-Activity Relationship of Oral Receptor Occupancy in the Brain for Orally Potent Antianxiety Drug
    Hayashi, Shigeo
    Hirao, Akiko
    Imai, Aki
    Nakamura, Hiroshi
    Murata, Yoshinori
    Ohashi, Katsuyo
    Nakata, Eriko
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (03) : 610 - 625
  • [8] Discovery of 1-[1-(1-Methylcyclooctyl)-4-piperidinyl]-2-[(3R)-3-piperidinyl]-1H-benzimidazole: Integrated Drug-Design and Structure-Activity Relationships for Orally Potent, Metabolically Stable and Potential-Risk Reduced Novel Non-Peptide Nociceptin/Orphanin FQ Receptor Agonist as Antianxiety Drug
    Hayashi, Shigeo
    Hirao, Akiko
    Nakamura, Hiroshi
    Yamamura, Kenzo
    Mizuno, Kunihiko
    Yamashita, Hiroyo
    CHEMICAL BIOLOGY & DRUG DESIGN, 2009, 74 (04) : 369 - 381
  • [9] Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: Design, synthesis, and structure-activity relationships
    Hayashi, Shigeo
    Nakata, Eriko
    Morita, Asato
    Mizuno, Kunihiko
    Yamamura, Kenzo
    Kato, Aki
    Ohashi, Katsuyo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (21) : 7675 - 7699
1